A NOVEL DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR EXPRESSING MEDULLOBLASTOMA
Publication
, Conference
Wilson, J; Wilkinson, D; Ryan, K; Bigner, D; Chambramohan, V; Fecci, P
Published in: NEURO-ONCOLOGY
2022
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2022
Volume
24
Start / End Page
228 / 229
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wilson, J., Wilkinson, D., Ryan, K., Bigner, D., Chambramohan, V., & Fecci, P. (2022). A NOVEL DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR EXPRESSING MEDULLOBLASTOMA. In NEURO-ONCOLOGY (Vol. 24, pp. 228–229).
Wilson, Joseph, Daniel Wilkinson, Katherine Ryan, Darell Bigner, Vidya Chambramohan, and Peter Fecci. “A NOVEL DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR EXPRESSING MEDULLOBLASTOMA.” In NEURO-ONCOLOGY, 24:228–29, 2022.
Wilson J, Wilkinson D, Ryan K, Bigner D, Chambramohan V, Fecci P. A NOVEL DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR EXPRESSING MEDULLOBLASTOMA. In: NEURO-ONCOLOGY. 2022. p. 228–9.
Wilson, Joseph, et al. “A NOVEL DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR EXPRESSING MEDULLOBLASTOMA.” NEURO-ONCOLOGY, vol. 24, 2022, pp. 228–29.
Wilson J, Wilkinson D, Ryan K, Bigner D, Chambramohan V, Fecci P. A NOVEL DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR EXPRESSING MEDULLOBLASTOMA. NEURO-ONCOLOGY. 2022. p. 228–229.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2022
Volume
24
Start / End Page
228 / 229
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences